Worsening of psychosis or topiramate-induced adverse event?
To access this article, please choose from the options below
PII: S0163-8343(03)00147-6
doi:10.1016/j.genhosppsych.2003.11.004
© 2004 Elsevier Inc. All rights reserved.
PII: S0163-8343(03)00147-6
doi:10.1016/j.genhosppsych.2003.11.004
© 2004 Elsevier Inc. All rights reserved.